Company

Vision

MetaImmuneTech empowers a new era of immune health by making immune diagnostics faster, simpler, and more accessible through digital in-line holography technology—transforming the way we monitor and manage immunity worldwide.

Mission

To advance immune health by delivering accessible and accurate
cell-based diagnostics powered by digital in-line holography.

History

2025
2024
2023

02

Certified with ISO13485 for medical device quality management system

04

Selected for the 2025 Agri-Food Venture Fostering Project (Ministry of Agriculture)

04

Selected for the 2025 Export Voucher Support Project (Ministry of SMEs and Startups)

04

Selected for the 2025 National Research Equipment Technology Competition (Ministry of Science and ICT)

04

Selected for the Tech Incubator Program for Startups (TIPS) Scale-up R&D project

06

Cellytics System received Grade 1 certification for in-vitro diagnostic devices

07

Cellytics NK – Winner of MEDITEK Innovation Award 2024 Best in Class

12

Minister of Science and ICT Award in Basic Science Division, Science and Technology Awards

03

Establishment of Corporate Research Institute (KU Sejong campus)

05

Science Belt R&D Grant awarded (MSIT, 1 billion KRW)

06

ITRC program awarded (MSIT)

08

CellyticsTM NK prototype completed (System + Reagent kit)

09

Clinical research of Cellytics NK in Hematologic cancer started (KUH Ansan)
Clinical research of Cellytics NK in Liver disease started (KUH Guro)
Clinical research in NSCLC patient monitoring with NK cell therpay (Vaxcell Bio, CNUHH)

10

Cellytics NK – CES 2024 Innovation Award Honoree (Digital Health)

12

Cellytics NK Sep-kit received Grade 1 certification for in-vitro diagnostic devices

Collaborators & Investors